04/21/2026
The filler backlash is everywhere but it is multifaceted. Most adverse filler outcomes aren’t a product problem. I often see a poor preparation problem, often patient led instead of clinical led. Specifically: no one assessed the biology of the tissue before injecting into it. Just a burger kind menu anyway you want. Thats not how injectables work.
I always start with pre-treatment tissue read and I’ll tell you why it matters:
•Barrier integrity isn’t just a skincare issue. When the skin barrier is compromised, it often signals essential fatty acid deficiency (think omega-3/6 imbalance), elevated cortisol from chronic stress, or gut-derived inflammation, all of which affect how filler integrates and how tissue heals.
•Undertone and tone changes are a visible inflammatory output. Measurable via hs-CRP, ferritin trends, or food sensitivity panels…creates an environment where filler behaves unpredictably, migration risk increases, and results degrade faster.
•Tissue laxity has multiple root causes. Collagen loss is one. But protein inadequacy (many patients consume under 50g/day), estrogen decline, and cortisol-driven muscle wasting all change the structural scaffolding of the face…meaning filler placed without addressing these is being layered onto an unstable foundation.
This is why the assessment is the treatment. It’s not a consultation formality. It’s diagnostic.